Dupilumab-Associated Eosinophilic Granulomatosis With Polyangiitis

Cureus. 2022 Aug 4;14(8):e27670. doi: 10.7759/cureus.27670. eCollection 2022 Aug.

Abstract

A 58-year-old Caucasian male developed generalized weakness, bilateral upper and lower extremity arthralgias, left pedal edema, and a new rash over two weeks after receiving one dose of dupilumab for chronic sinusitis. He was found to be positive for perinuclear anti-neutrophil cytoplasmic antibodies and myeloperoxidase, with evidence of interstitial lung disease on CT imaging. A skin biopsy showed eosinophilic vasculitis and a kidney biopsy showed pauci-immune glomerulonephritis. He was diagnosed with eosinophilic granulomatosis with polyangiitis due to dupilumab exposure.

Keywords: atopic disease; chronic sinusitis; dupilumab; eosinophilic granulomatosis with polyangiitis; human igg4 monoclonal antibody.

Publication types

  • Case Reports